Bathi sadurunge mbayar bunga, pajak, lan amortisasi: GSK plc (GSK)

Operating cash flow before interest and taxes reflects the profit dynamics of GSK plc (GSK), where 14190.22 expresses the current value of the metric. Geopolitical instability is currently hindering component logistics and the execution of global trials. Meanwhile, GSK plc (GSK) relies on its leadership in immunology and the high pricing power of its vaccines. Business stability is based on the approval of new HIV treatments and the management of legacy legal risks.

gsk.com (GSK) - Bathi operasional EBITDA saka 23.11.2025 nganti 10.11.2026

GlaxoSmithKline (GSK) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:

Rega bursa GlaxoSmithKline plc|GSK - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Nilai pasar GSK|GSK - Nilai Perusahaan

- rincian valuasi buku bisnis:

Ekuitas saben Saham GSK|GSK - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku gsk.com|GSK - Aset Agregat Perusahaan

- rincian struktur utang lan likuiditas bisnis:

- indikator bathi lan kelipatan valuasi:

GSK - Penghasilan resik|Penghasilan resik sing dikarepake GSK plc|GSK - Rasio rega marang bathi|Rasio rega marang bathi sing dikarepake GlaxoSmithKline plc|GSK - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan GSK|GSK - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan GSK|GSK - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham sajroning taun lumaku gsk.com|GSK - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep GSK plc

Ringkesan analitik perusahaan:GSK, GSK plc

Absolute operating profit measures the net cash flow from core operations before taxes and interest. Investors use this indicator to assess a business's actual ability to generate liquidity. By analyzing absolute EBITDA, one can track the impact of the cost of capital on margins. For GSK plc (GSK), such cash flow stability provides the funding for the environmental modernization of its plants. This allows the company to implement "green" technologies in inhaler production without compromising financial stability.

Pesaing GSK plc (GSK)

Eli Lilly and Co. (LLY) - Bathi sadurunge bunga, pajak, lan amortisasi|ABBV - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|AZN: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|NVS: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi MRK|NVO (Novo Nordisk Inc.) - Bathi operasional EBITDA|Amgen Inc (AMGN) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Pfizer Inc. (PFE)|sanofi.com - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA BMY (Bristol Myers Squibb)|Bathi operasional sadurunge potongan amortisasi Takeda Pharmaceutical Company|Teva Pharmaceutical Industries Ltd. - Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi Dr. Reddy's Labs (RDY)|Viatris Inc. (VTRS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|ROIV - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Zai Lab|Bathi operasional EBITDA Bausch Health Companies Inc.|Bathi operasional sadurunge ngurangi amortisasi COSM (Cosmos Holdings)